Bench:Naresh H. Patil
3 IP cases indexed. Covers patent matters.
Cases Presided Over
3 cases indexed | Page 1 of 1
Panacea Biotec Limited v.Union of India and others
Panacea Biotec Ltd. challenged the grant of its vaccine patent (IN'351) after the Opposition Board provided a recommendation that the Petitioner deemed 'flawed.' The Petitioner sought the High Court to reconstitute a new Opposition Board. The court rejected the petition, holding that the Act provides a self-contained mechanism for expert adjudication and judicial interference is unwarranted at this stage.
Ansari Bilal Ahmadlal Mohd. (Appellant) v.Shafeeque Ahmed Mohammad Sayeed (Respondent-Plaintiff)
The Bombay High Court dismissed the defendant's commercial appeal, upholding the original plaintiff's claim of passing off. The court found that a strong prima-facie case existed for passing off, despite differences in calligraphy and design elements. Considering the target audience—laborers with imperfect recollection—the court ruled that the defendant's use of 'SUKOON' was deceptively similar to the plaintiff's established brand, thereby protecting the plaintiff's proprietary rights.
Deccan Bottling & Distilling Industries Private Limited v.Brihan Maharashtra Sugar Syndicate Limited
The Bombay High Court dismissed an appeal filed by Deccan Bottling & Distilling Industries Private Limited against a temporary injunction granted in favor of Brihan Maharashtra Sugar Syndicate Limited. The dispute centered on alleged passing off and trademark infringement related to country liquor labels ('Paru Santra' vs 'Sakhu Santra'). While the trial court had found prima facie evidence of deceptive similarity, the High Court upheld this finding, confirming that the plaintiff (respondent) had established a sufficient case for injunction based on the visual impression of the competing marks.
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.